Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Kinaset Therapeutics
AddedFeb 17, 2024
UpdatedJun 18, 2026
Kinaset Therapeutics

Kinaset Therapeutics

Series A

Kinaset Therapeutics develops novel respiratory drugs to address unmet medical needs.

HQ
Medfield, MA, US
Founded
2020
Overview
Compare
Fundraising
Employees
Website

Kinaset Therapeutics, founded with a mission to address unmet medical needs in respiratory health, focuses on developing innovative inhaled therapeutics for respiratory diseases. The company aims to create novel drugs that can significantly improve the quality of life for individuals suffering from intractable respiratory conditions. Their product pipeline is centered around advanced respiratory treatments designed to offer new hope where existing therapies fall short.

Notable figures affiliated with Kinaset Therapeutics include experienced professionals from the pharmaceutical and biotech industries, contributing their expertise to drive the company's mission forward. The company has attracted investment from leading venture capital firms, underscoring confidence in its potential impact. Key achievements include the development of promising drug candidates that have shown efficacy in preclinical studies, positioning Kinaset Therapeutics as a significant player in the respiratory therapeutics market.

Kinaset Therapeutics - Similar Companies

Respira Therapeutics logo

Respira Therapeutics

KinDex Pharmaceuticals logo

KinDex Pharmaceuticals

Kiniksa Pharmaceuticals logo

Kiniksa Pharmaceuticals

kiniksa.com

Metera Pharmaceuticals logo

Metera Pharmaceuticals

Axikin Pharmaceuticals logo

Axikin Pharmaceuticals

Aer Therapeutics logo

Aer Therapeutics

Aero Therapeutics logo

Aero Therapeutics

Therabron Therapeutics logo

Therabron Therapeutics

therabron.com

Pneuma Respiratory logo

Pneuma Respiratory

Kestrel Therapeutics logo

Kestrel Therapeutics

Kwivik Therapeutics logo

Kwivik Therapeutics

kwivikmedical.com

Transpire Bio logo

Transpire Bio

transpirebio.com

Pulmokine logo

Pulmokine

pulmokine.net

Pulmatrix logo

Pulmatrix

pulmatrix.com

Theracos logo

Theracos

theracos.com

Kinaset Therapeutics - Quick Facts

Who are Kinaset Therapeutics' competitors?

Companies similar to Kinaset Therapeutics include Respira Therapeutics, KinDex Pharmaceuticals, Kiniksa Pharmaceuticals and Metera Pharmaceuticals.

When was Kinaset Therapeutics founded?

Kinaset Therapeutics was founded in 2020.

Where is Kinaset Therapeutics' headquarters located?

Kinaset Therapeutics' headquarters is located in Medfield, MA, US.

When was Kinaset Therapeutics' last funding round?

Kinaset Therapeutics' most recent funding round was for $40M (USD) in November 2020.

How much has Kinaset Therapeutics raised to-date?

As of Nov 30, 2020, Kinaset Therapeutics has raised a total of $41.5M (USD).

How many employees does Kinaset Therapeutics have?

Kinaset Therapeutics has 11 employees as of Feb 5, 2024.

Kinaset Therapeutics - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Respiratory Drugs
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified